HIV is transmitted when certain body fluids from a person with HIV enter another person's body under conditions that allow transmission. Sexual exposure and sharing injection equipment are important routes of transmission, while transmission can also occur from parent to child during pregnancy, birth, or breastfeeding. Understanding these routes helps explain why different HIV risk reduction methods focus on reducing exposure, identifying HIV status, and limiting circumstances in which transmission can occur. Activities that do not involve contact with relevant body fluids generally present little or no HIV transmission risk. Risk can also vary depending on the type of sexual activity and whether protective measures are consistently used.
A useful way to understand prevention is to consider risk reduction as a combination of complementary strategies rather than one universal method. WHO describes combination prevention as an approach that brings together biomedical, behavioral, and structural interventions according to the needs of individuals and communities. This framework recognizes that circumstances can change over time, so prevention planning may also need to change.
Condoms are an established component of HIV prevention because they can reduce contact with body fluids during sexual activity when used correctly and consistently. They can also provide protection against certain other sexually transmitted infections and can contribute to pregnancy prevention. Their effectiveness depends partly on correct use, consistent use, proper storage, and choosing an appropriate product for the situation. Condoms do not eliminate every possible sexual health risk because some infections can spread through skin-to-skin contact in areas not covered by a condom.
Sexual choices can also affect HIV exposure. Some activities involve little or no opportunity for HIV transmission because they do not involve contact with relevant body fluids. Understanding these differences allows people to consider their circumstances and select prevention measures accordingly. Combining barrier protection with other risk reduction approaches can provide additional layers of protection, particularly when circumstances or exposure patterns change.
Regular HIV testing is another important part of risk reduction because a person cannot reliably determine HIV status from symptoms alone. Testing can provide information that supports appropriate prevention planning and, when needed, connection to healthcare. Testing for other sexually transmitted infections can also be useful because some infections can increase susceptibility to HIV.
Awareness of HIV status can also support prevention between partners. For people living with HIV, consistent healthcare and effective management can reduce the amount of virus in the blood to an undetectable level. WHO states that people receiving effective treatment who have no detectable virus do not transmit HIV sexually. This principle is commonly summarized as undetectable equals untransmittable, or U=U. Understanding this evidence can help reduce misinformation while emphasizing the importance of appropriate testing and ongoing healthcare.
For people who do not have HIV but may have substantial exposure risk, additional prevention options are available through healthcare systems. These approaches are designed to reduce the likelihood that HIV becomes established after potential exposure or to provide ongoing protection before exposure. Their availability, eligibility requirements, testing procedures, and recommended schedules can vary by country and individual circumstances.
Current international guidance includes several forms of prevention based on medicines administered before potential exposure, including oral and longer-acting options. WHO expanded its recommended prevention choices in 2025 to include a twice-yearly injectable option, while continuing to support a range of prevention choices. These developments illustrate how HIV prevention is becoming more diverse, allowing prevention strategies to be considered according to different needs and preferences.
Sharing needles, syringes, or other injection equipment can create a direct pathway for blood-to-blood transmission. Avoiding shared equipment is therefore an important HIV risk reduction measure for people who inject substances. Harm reduction programs can provide access to sterile injection equipment and other health resources while creating opportunities for HIV testing and healthcare support.
The principle behind this approach is straightforward: preventing contaminated blood from being transferred between people reduces an important opportunity for transmission. Harm reduction can also connect people with broader health services, including testing and support for other infections. WHO identifies harm reduction as part of comprehensive HIV prevention approaches, demonstrating that prevention can involve both individual practices and community-level programs.
No single HIV risk reduction method necessarily addresses every possible exposure. Combination prevention brings together approaches that address different pathways of transmission. For example, someone may combine condom use with regular testing and an appropriate ongoing prevention strategy. Another person may focus on sterile equipment practices, testing, and healthcare support. The relevant combination depends on individual circumstances, exposure patterns, access to healthcare, and local recommendations.
Combination approaches are also adaptable. A person's circumstances can change because of relationships, sexual practices, health status, or other factors. Prevention planning can therefore be revisited periodically rather than treated as a permanent one-time decision. WHO recommends prevention approaches that are evidence-informed, rights-based, and tailored to populations and settings.
Accurate information is an important part of HIV risk reduction because misconceptions can lead people to underestimate or overestimate particular forms of exposure. Understanding transmission routes, recognizing the role of testing, and knowing which prevention methods address specific risks can support more informed decisions. It is also important to recognize that HIV prevention guidance can change as evidence develops and new prevention choices become available.
People considering prevention options should use current guidance from qualified healthcare professionals and public health organizations, particularly when a potential exposure has already occurred. Prevention strategies may require testing or other assessments before they are started or continued. Keeping information current helps ensure that risk reduction decisions reflect contemporary evidence rather than outdated assumptions.
HIV risk reduction methods and how they work can be understood through several complementary principles: reducing exposure, using appropriate barriers, maintaining awareness of HIV status, avoiding shared injection equipment, and considering evidence-based prevention options when relevant. Combination prevention is particularly important because different methods address different circumstances and can work together as part of a broader prevention strategy. As prevention research and public health guidance continue to evolve, accurate information remains essential for understanding available choices and their appropriate use.